SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-045962
Filing Date
2019-08-14
Accepted
2019-08-14 17:18:21
Documents
1
Period of Report
2019-08-12

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 13855
  Complete submission text file 0001104659-19-045962.txt   15185
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O AMPHASTAR PHARMACEUTICALS INC 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address
Liawatidewi Yakob (Reporting) CIK: 0001743927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 191027619